BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18191026)

  • 1. Casein kinase 1 alpha associates with the tau-bearing lesions of inclusion body myositis.
    Kannanayakal TJ; Mendell JR; Kuret J
    Neurosci Lett; 2008 Jan; 431(2):141-5. PubMed ID: 18191026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel demonstration of conformationally modified tau in sporadic inclusion-body myositis muscle fibers.
    Nogalska A; D'Agostino C; Engel WK; Askanas V
    Neurosci Lett; 2011 Oct; 503(3):229-33. PubMed ID: 21896314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Casein kinase-1 isoforms differentially associate with neurofibrillary and granulovacuolar degeneration lesions.
    Kannanayakal TJ; Tao H; Vandre DD; Kuret J
    Acta Neuropathol; 2006 May; 111(5):413-21. PubMed ID: 16557393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau aggregates are abnormally phosphorylated in inclusion body myositis and have an immunoelectrophoretic profile distinct from other tauopathies.
    Maurage CA; Bussière T; Sergeant N; Ghesteem A; Figarella-Branger D; Ruchoux MM; Pellissier JF; Delacourte A
    Neuropathol Appl Neurobiol; 2004 Dec; 30(6):624-34. PubMed ID: 15541003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis.
    Nogalska A; Terracciano C; D'Agostino C; King Engel W; Askanas V
    Acta Neuropathol; 2009 Sep; 118(3):407-13. PubMed ID: 19557423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant ubiquitin UBB+1 is accumulated in sporadic inclusion-body myositis muscle fibers.
    Fratta P; Engel WK; Van Leeuwen FW; Hol EM; Vattemi G; Askanas V
    Neurology; 2004 Sep; 63(6):1114-7. PubMed ID: 15452314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy.
    Askanas V; Engel WK; Yang CC; Alvarez RB; Lee VM; Wisniewski T
    Am J Pathol; 1998 Apr; 152(4):889-95. PubMed ID: 9546349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin-dependent kinase 5 colocalizes with phosphorylated tau in human inclusion-body myositis paired-helical filaments and may play a role in tau phosphorylation.
    Wilczynski GM; Engel WK; Askanas V
    Neurosci Lett; 2000 Oct; 293(1):33-6. PubMed ID: 11065131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies.
    Mirabella M; Alvarez RB; Bilak M; Engel WK; Askanas V
    J Neuropathol Exp Neurol; 1996 Jul; 55(7):774-86. PubMed ID: 8965093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twisted tubulofilaments of inclusion body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau.
    Askanas V; Engel WK; Bilak M; Alvarez RB; Selkoe DJ
    Am J Pathol; 1994 Jan; 144(1):177-87. PubMed ID: 8291607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-beta precursor protein-overexpressing cultured human muscle fibers.
    Fratta P; Engel WK; McFerrin J; Davies KJ; Lin SW; Askanas V
    Am J Pathol; 2005 Aug; 167(2):517-26. PubMed ID: 16049336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sporadic inclusion-body myositis: conformational multifactorial ageing-related degenerative muscle disease associated with proteasomal and lysosomal inhibition, endoplasmic reticulum stress, and accumulation of amyloid-β42 oligomers and phosphorylated tau.
    Askanas V; Engel WK
    Presse Med; 2011 Apr; 40(4 Pt 2):e219-35. PubMed ID: 21392932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion body myositis in Alzheimer's disease.
    Roos PM; Vesterberg O; Nordberg M
    Acta Neurol Scand; 2011 Sep; 124(3):215-7. PubMed ID: 21824117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three lipoprotein receptors and cholesterol in inclusion-body myositis muscle.
    Jaworska-Wilczynska M; Wilczynski GM; Engel WK; Strickland DK; Weisgraber KH; Askanas V
    Neurology; 2002 Feb; 58(3):438-45. PubMed ID: 11839845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rimmed vacuoles with beta-amyloid and tau protein deposits in the muscle of children with hereditary myopathy.
    Fidziańska A; Glinka Z
    Acta Neuropathol; 2006 Aug; 112(2):185-93. PubMed ID: 16788822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sporadic inclusion-body myositis: A degenerative muscle disease associated with aging, impaired muscle protein homeostasis and abnormal mitophagy.
    Askanas V; Engel WK; Nogalska A
    Biochim Biophys Acta; 2015 Apr; 1852(4):633-43. PubMed ID: 25241263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic considerations in sporadic inclusion-body myositis, a degenerative muscle disease associated with aging and abnormalities of myoproteostasis.
    Askanas V; Engel WK; Nogalska A
    J Neuropathol Exp Neurol; 2012 Aug; 71(8):680-93. PubMed ID: 22805774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E and apolipoprotein E messenger RNA in muscle of inclusion body myositis and myopathies.
    Mirabella M; Alvarez RB; Engel WK; Weisgraber KH; Askanas V
    Ann Neurol; 1996 Dec; 40(6):864-72. PubMed ID: 9007091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nature of "Tau" immunoreactivity in normal myonuclei and inclusion body myositis.
    Salajegheh M; Pinkus JL; Nazareno R; Amato AA; Parker KC; Greenberg SA
    Muscle Nerve; 2009 Oct; 40(4):520-8. PubMed ID: 19626672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of autophagic proteins in the skeletal muscle of sporadic inclusion body myositis.
    Girolamo F; Lia A; Amati A; Strippoli M; Coppola C; Virgintino D; Roncali L; Toscano A; Serlenga L; Trojano M
    Neuropathol Appl Neurobiol; 2013 Dec; 39(7):736-49. PubMed ID: 23452291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.